HIGHLIGHTS
- who: Lin et_al Experimental Hematology et al. from the (UNIVERSITY) have published the research: CORRESPONDENCE Open Access, in the Journal: (JOURNAL)
- what: The 64th ASH annual meeting presented a series of efficacy and safety data on BsAbs used in monotherapy or in combination.
SUMMARY
As presented at the 64th American Society of Hematology (ASH) Annual Meeting, several trials are ongoing to further confirm their efficacy and tolerability, as well as optimal timing and combinations. The authors conducted this review to further elucidate the efficacy and safety of BsAbs for B-NHL . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.